|
WO2021008491A1
|
|
Biphenyl derivatives for blocking pd-1/pd-l1 interaction, preparation method therefor and use thereof
|
|
WO2020221209A1
|
|
Cd73 inhibitor, preparation method therefor and application thereof
|
|
WO2020220562A1
|
|
Benzofuran-6-formamide derivative, preparation method therefor, and pharmaceutical application thereof
|
|
WO2020151232A1
|
|
1,2,3,4-tetrahydroquinoxaline derivative, preparation method therefor and application thereof
|
|
WO2020082921A1
|
|
Nitrogen heteroaryl amide derivative, preparation method therefor, and application thereof
|
|
CN112119064A
|
|
FGFR inhibitor, preparation method and application thereof
|
|
CN110845476A
|
|
High-selectivity CSF1R inhibitor, preparation method and pharmaceutical application thereof
|
|
CN111886219A
|
|
Immunosuppressant, preparation method and pharmaceutical application thereof
|
|
WO2019242587A1
|
|
Highly selective fgfr i inhibitor, preparation method therefor and use thereof
|
|
CN111868058A
|
|
FGFR inhibitor, preparation method and pharmaceutical application thereof
|
|
KR20200100717A
|
|
Biaryl derivatives, their synthesis and their pharmaceutical use
|
|
CN111094317A
|
|
Phosphonic acid derivative with CD73 inhibitory activity, and preparation method and application thereof
|
|
CN109456374A
|
|
A kind of SGLTs protein inhibitor, preparation method and application pharmaceutically
|
|
CA3069602A1
|
|
Formylpyridine derivative having fgfr4 inhibitory activity, preparation method therefor and use thereof
|
|
CN110461841A
|
|
A kind of azepine aryl derivatives, preparation method and application with CSF1R inhibitory activity
|
|
CN110461849A
|
|
A kind of CSF1R inhibitor and its preparation method and application
|
|
CN110546145A
|
|
Azaaryl derivative, preparation method and pharmaceutical application thereof
|
|
AU2018274043A1
|
|
N-(azaaryl)cyclolactam-1-carboxamide derivative, preparation method therefor, and use thereof
|
|
KR20190092376A
|
|
FGFR4 inhibitors, methods for their preparation and pharmaceutical applications
|
